# Progesterone vs Placebo Therapy for Women With Epilepsy

> **NCT00029536** · PHASE3 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 294 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **BIOLOGICAL:** Progesterone Lozenges
- **OTHER:** Matched Placebo Lozenges

## Key facts

- **NCT ID:** NCT00029536
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2017-06-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029536, "Progesterone vs Placebo Therapy for Women With Epilepsy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00029536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*